Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Acute Lymphocytic Leukemia (ALL) in Adults
There are only a handful of known risk factors for acute lymphocytic leukemia (ALL), also known as acute lymphoblastic leukemia.
A risk factor is something that increases your chance of getting a disease such as cancer. Some risk factors, like smoking, can be controlled. Others, like your age or family history, can’t be changed.
But having a risk factor, or even several risk factors, doesn’t mean you will get the disease. And many people who get the disease may have few or no known risk factors.
Here is what we know about risk factors for ALL.
High levels of exposure: Exposure to high levels of radiation is a risk factor for both ALL and acute myeloid leukemia (AML). For example, Japanese atomic bomb survivors had a greatly increased risk of developing acute leukemia.
Radiation therapy: Treating cancer with radiation therapy also increases the risk of ALL. The risk seems to be higher if chemotherapy and radiation are both used in treatment.
Medical imaging tests: Being exposed to lower levels of radiation from medical imaging tests like x-rays and CT scans may also be a risk factor for ALL (and other leukemias). But the possible risks are not well understood.
Exposure to certain chemotherapy drugs and other chemicals, including benzene, may increase the risk of ALL. Benzene is used in many industries to make other products. It is also in cigarette smoke, gasoline and motor vehicle exhaust, and some glues, cleaning products, detergents, art supplies, and paint strippers.
Chemical exposure is more strongly linked to an increased risk of AML than to ALL.
Infection with the human T-cell lymphoma/leukemia virus-1 (HTLV-1) can cause a rare type of T-cell ALL. Most cases occur in Japan and the Caribbean area. This disease is not common in the United States.
In Africa, the Epstein-Barr virus (EBV) has been linked to Burkitt lymphoma, as well as to a form of ALL. In the United States, EBV most often causes infectious mononucleosis (“mono”). It has also been linked to a type of lymphoma that can happen after a stem cell transplant. This is known as post-transplant lymphoproliferative disorder, or PTLD.
ALL itself doesn't seem to run in families, so a person’s risk is not increased if a family member has the disease (other than an identical twin — see below).
But there are some genetic syndromes (some of which can be inherited from a parent) that seem to raise the risk of ALL.
These include:
ALL is more likely to happen in young children and in adults over the age of 50.
ALL is more common in White people than in Black people. The reasons for this aren’t clear.
ALL is more common in males than in females. The reason for this isn’t clear.
Someone with an identical twin who develops ALL in the first year of life has an increased risk of getting ALL.
Other factors that have been studied for a possible link to ALL include:
So far, none of these factors have been linked conclusively to ALL, but research in these areas continues.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Appelbaum FR. Chapter 95: Acute Leukemias in Adults. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
National Cancer Institute. Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version. 2025. Accessed at https://www.cancer.gov/types/leukemia/patient/adult-all-treatment-pdq on May 5, 2025.
National Cancer Institute. SEER Cancer Stat Facts: Acute Lymphocytic Leukemia (ALL). Accessed at https://seer.cancer.gov/statfacts/html/alyl.html on May 6, 2025.
Last Revised: August 13, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.